SILENCE THERAPEUTICS

silence-therapeutics-logo

Silence Therapeutics plc is a United Kingdom-based ribonucleic acid (RNA) technology company. The Company is primarily involved in the research and development of pharmaceutical products. The Company's technology harnesses the body's natural mechanisms to create therapeutic effects within its own cells. The Company has a has a genetic toolkit with its own therapeutic payloads to modulate gene expression up as well as down in preclinical in vivo models, and delivery systems for various organs and cell types.

#SimilarOrganizations #People #Financial #Event #Website #More

SILENCE THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Information Technology Medical Therapeutics

Founded:
1999-01-01

Address:
London, England, United Kingdom

Country:
United Kingdom

Website Url:
http://www.silence-therapeutics.com

Total Employee:
11+

Status:
Active

Contact:
+4402037009711

Email Addresses:
[email protected]

Total Funding:
128.7 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Content Delivery Network Google Universal Analytics Domain Not Resolving Euro ReCAPTCHA Cloudflare SSL


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

not_available_image

Future Medical Technologies

Future Medical Technologies is engaged in the development of its proprietary HydraCartilage technology.

intellia-therapeutics-logo

Intellia Therapeutics

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

interline-therapeutics-logo

Interline Therapeutics

Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.

norinvents-logo

NorInvents

NorInvents is a development company in the field of life science, which develops Drug Delivery platforms.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

Current Employees Featured

dmitry-samarsky_image

Dmitry Samarsky
Dmitry Samarsky Chief Scientific Officer @ Silence Therapeutics
Chief Scientific Officer

craig-tooman_image

Craig Tooman
Craig Tooman President and Chief Executive Officer @ Silence Therapeutics
President and Chief Executive Officer
2022-02-01

adrien-weingรคrtner_image

Adrien Weingรคrtner
Adrien Weingรคrtner Group Leader Drug Delivery @ Silence Therapeutics
Group Leader Drug Delivery
2017-11-01

john-strafford_image

John Strafford
John Strafford SVP, Head of Business Development, Alliance Management and New Product Development @ Silence Therapeutics
SVP, Head of Business Development, Alliance Management and New Product Development
2021-09-01

stephen-parker_image

Stephen Parker
Stephen Parker Director @ Silence Therapeutics
Director
2013-11-01

iain-ross_image

Iain Ross
Iain Ross Chairman @ Silence Therapeutics
Chairman
2019-04-01

Stock Details


Company's stock symbol is LSE:SLN

Acquisitions List

Date Company Article Price
2009-12-16 Intradigm Corporation Intradigm Corporation acquired by Silence Therapeutics N/A

Investors List

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Post-IPO Equity - Silence Therapeutics

adage-capital-management_image

Adage Capital Management

Adage Capital Management investment in Post-IPO Equity - Silence Therapeutics

bvf-partners_image

BVF Partners

BVF Partners investment in Post-IPO Equity - Silence Therapeutics

consonance-capital-partners_image

Consonance Capital Partners

Consonance Capital Partners investment in Post-IPO Equity - Silence Therapeutics

great-point-partners_image

Great Point Partners

Great Point Partners investment in Post-IPO Equity - Silence Therapeutics

mallinckrodt_image

Mallinckrodt

Mallinckrodt investment in Post-IPO Equity - Silence Therapeutics

Investments List

Date Company Article Money raised
2017-01-10 Arrowhead Pharmaceuticals Silence Therapeutics investment in Post-IPO Equity - Arrowhead Pharmaceuticals 9.6 M USD

Official Site Inspections

http://www.silence-therapeutics.com Semrush global rank: 3.78 M Semrush visits lastest month: 3.57 K

Unable to get host informations!!!

Loading ...

More informations about "Silence Therapeutics" on Search Engine